.png){kind=icon}
.png){kind=icon}
Return
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in the 20-Valent Pneumococcal Conjugate Vaccine in the Adult Population in France
.png){kind=icon}
OA
AI
E
S
E
J
M
L
DOI：10.1093/ofid/ofag381.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Streptococcus pneumoniae causes invasive pneumococcal disease and pneumonia. This study models the burden of adult pneumococcal disease in France. Over a 5-year period, approximately 630,000 cases and €3.1 billion of costs were attributable to pneumococcus, mostly non-invasive disease, with nearly 80% due to serotypes included in 20-valent pneumococcal conjugate vaccine.
Journal
IF:
3.8
Papers:
6.3K
Citations:
1.4W
Organization
Cited Papers